Profound Medical Corp. PROF
6.86 USD +0.13 +1.93%
As of Nov 3, 2:08 PM ET
- YTD
- -12.83%
- 1 year
- +15.10%
- Open
- 6.70
- Prev close
- 6.73
- Mkt cap
- 250.67M
- Vol
- 49.83K
- Avg vol
- 193.59K
- EPS
- -0.99
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.70
- High
- 6.94
- Forward P/E
- -7.95
- Beta
- 0.83
- Short ratio
- 7.87
- Inst. own
- 35.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 7.73
- 200-d avg
- 8.29
- 1y target
- 15.30
15m chart
Chart tools
Chart is warming up
The fifteen-minute interval price history for PROF has not been loaded yet. Try again in a moment.
Altman Z-Score
9.01 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
P/E -5.5×
P/S 14.5×
P/B 2.6×
P/FCF -6.1×
EV/EBITDA -3.9×
EV/Sales 9.9×
FCF Yield -16.4%
Gross Margin 70.8%
Operating Margin -256.3%
Net Margin -264.4%
ROE -47.6%
ROIC -22.7%
ROA -22.4%
Revenue 61.1%
Operating Income -33.4%
EPS (diluted) -33.6%
Free Cash Flow -66.5%
Current Ratio 12.5×
Quick Ratio 11.2×
Debt / Equity 0.1×
Net Debt / EBITDA 1.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31